Brown Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.53M Sell
248,896
-108,817
-30% -$904K 0.22% 53
2025
Q4
$3.73M Sell
357,713
-413,467
-54% -$4.15M 0.31% 50
2025
Q3
$6.93M Sell
771,180
-348,060
-31% -$3.05M 0.29% 48
2025
Q2
$14.6M Buy
1,119,240
+171,952
+18% +$2.59M 0.42% 45
2025
Q1
$23.9M Buy
947,288
+105,096
+12% +$3.12M 0.72% 43
2024
Q4
$29M Buy
842,192
+299,755
+55% +$13.5M 0.67% 40
2024
Q3
$26.8M Buy
+542,437
New +$27.8M 0.58% 41

Other funds holding RXST

Brown Capital Management's RXST Position: Q1 2026 in Review

Brown Capital Management reduced its RxSight (RXST) stake by 30% in Q1 2026, selling an estimated $904K and leaving 248,896 shares worth $1.53M. The position accounts for 0.22% of the portfolio, ranked #53.

Brown Capital Management first reported a position in RXST in Q3 2024 and has held it in 7 quarters since. The position peaked at $29M in Q4 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Brown Capital Management held 248,896 shares of RxSight worth $1.53M as of Q1 2026.
  • Brown Capital Management sold 108,817 RxSight shares in Q1 2026, an estimated $904K.
  • RxSight made up 0.22% of Brown Capital Management's portfolio in Q1 2026, its #53 holding.
  • Brown Capital Management first reported a position in RxSight in Q3 2024 and has held it in 7 quarters since.
  • Brown Capital Management's RxSight position peaked at $29M in Q4 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Brown Capital Management's 13F filing for Q1 2026, filed 14 May 2026.